Combined administration of naringenin and hesperetin with optimal ratio maximizes the anti-cancer effect in human pancreatic cancer via down regulation of FAK and p38 signaling pathway

Title
Combined administration of naringenin and hesperetin with optimal ratio maximizes the anti-cancer effect in human pancreatic cancer via down regulation of FAK and p38 signaling pathway
Authors
Keywords
Naringenin, Hesperetin, Optimal ratio, Pancreatic cancer
Journal
PHYTOMEDICINE
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2018-11-21
DOI
10.1016/j.phymed.2018.11.022

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now